Dr. Tailin is an epidemiologist specializing in pharmacology, cerebrovascular and inflammatory diseases, and stem cell biology. He holds a PhD in Biology from Southern University of Science and Technology. He is currently the joint postdoctoral fellow in Chinese Academy of Sciences and the Second Affiliated Hospital of Southern University of Science and Technology. He currently leads several national research projects and has published 12 peer-reviewed papers in internationally renowned journals including Acta Pharmaceutica Sinica B, Bone Research, Cell Death and Differentiation, and Signal Transduction and Targeted Therapy over the past 5 years.